Optical coherence tomography (OCT) has proven instrumental to objectively characterize cystoid macular edema (CME) from central retinal vein occlusion (CRVO).
1,2 This imaging modality can quantify retinal thickness changes in eyes with CME,
1 and is superior to contact lens–assisted biomicroscopy to identify foveal edema.
3 Macular edema is a major contributor to vision loss in patients with CRVO, and OCT has been especially useful to monitor macular edema treatment.
4–8 In addition to characterizing CME, OCT can facilitate identification of associated visually significant pathologies such as subretinal fluid (SRF),
9 epiretinal membrane (ERM),
10 and vitreomacular adhesion (VMA).
11 For these reasons, OCT has been used to monitor eyes of patients who participated in recent interventional trials for CRVO. For example, OCT has been used for this purpose in the Central Retinal Vein Occlusion Study (CRUISE), Global Evaluation of Implantable Dexamethasone in Retinal Vein Occlusion with Macular Edema study (OZURDEX GENEVA), and Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study.
4–6 Though OCT has been used in these and other clinical trials for CRVO, the OCT grading methodologies vary across studies. For example, in the SCORE trial, OCT images were typically evaluated by a single reader in contrast to the team-based approach used at our reading center as described below.
To accurately measure macular edema secondary to CRVO, it is important that central retinal thickness measurements be reproducible. Though this goal is straightforward, it is not always so simple to obtain these measurements. For example, during the SCORE trial analysis of central retinal thickness, it was noted that 28.9% of OCT scans required remeasurement with handheld calipers. The most frequent indication for these manual corrections was automated segmentation error.
5 Other groups have reported that inaccurate automated retinal thickness measurements from OCT software segmentation algorithms are common.
12–15 In one study that reviewed manual remeasurement in over 2000 OCT scans,
14 incorrect automated segmentation placement was noted as the most common indication for segmentation error correction.
Segmentation errors are frequent, and the magnitude of central retinal thickness measurement error caused by misplaced segmentation lines in eyes with CRVO can be substantial. A smaller study of 28 eyes with retinal vein occlusion reported a 129-μm error in automated mean retinal center point measurement.
14 This study, however, did not examine the precision of measurement corrections performed. Also, particular CRVO-associated morphological characteristics on OCT may be associated with higher rates of segmentation error corrections (SEC). If these OCT factors were known and identified in an eye with CRVO, then reading center readers and managing clinicians could better predict when segmentation errors would occur on automated measurements. Finally, reproducible measurement of change in central retinal thickness is particularly important since this parameter is a key secondary endpoint of interventional trials for CRVO such as the COPERNICUS trial described in the present report.
In the current study, we describe for the first time, to the best of our knowledge, the reproducibility of a team-based approach to grade OCT images generated during an interventional, multicenter trial of CRVO-associated macular edema and the reproducibility of SEC. The impact of segmentation errors on automated measurement of central retinal thickness and OCT morphological findings associated with the need for SEC were also determined.